Compounds > treosulfan
Page last updated: 2024-08-21

treosulfan and Breast Neoplasms

treosulfan has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altgassen, C; Friedrich, M; Terjung, A1
Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P1
Mauch, C1
Köpf-Maier, P; Sass, G1

Other Studies

4 other study(ies) available for treosulfan and Breast Neoplasms

ArticleYear
Treosulfan for advanced breast cancer in a heavily pre-treated patient - a case report.
    European journal of gynaecological oncology, 2017, Volume: 38, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Busulfan; Female; Humans; Lung Neoplasms; Middle Aged; Tomography, X-Ray Computed

2017
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
    BMC cancer, 2004, Nov-23, Volume: 4

    Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gefitinib; Gemcitabine; Humans; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Quinazolines; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Uveal Neoplasms

2004
[Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:1

    Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bevacizumab; Breast Neoplasms; Busulfan; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Melanoma; Neoplasm Metastasis; Neoplasms; Prospective Studies; Quality of Life; Skin Neoplasms; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005
Antitumor activity of treosulfan against human breast carcinomas.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Cell Division; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous

1992